Substrate binding in human indoleamine 2,3-dioxygenase 1: A spectroscopic analysis

Area of Science:

• Biochemistry
• Structural Biology
• Enzymology

Background:

• Human indoleamine 2,3-dioxygenase (hIDO1) is a heme enzyme crucial in tryptophan metabolism.
• Elevated hIDO1 expression in tumors correlates with poor cancer prognosis, making it a significant therapeutic target.
• Understanding the structural basis of hIDO1 activity is essential for developing selective inhibitors.

Purpose of the Study:

• To elucidate the structural requirements for substrate binding and catalysis in hIDO1.
• To identify key amino acid residues and conformational changes involved in hIDO1-substrate interaction.
• To guide the design of novel, selective hIDO1 inhibitors for cancer therapy.

Main Methods:

• Fourier transform infrared (FTIR) spectroscopy.
• Nanosecond time-resolved optical spectroscopy.
• Analysis of hIDO1 variants with modified heme pocket structures.

Main Results:

• Identified a cluster of small side chain residues (260-265) crucial for active site flexibility.
• Determined that Thr379 and Arg231 are key residues for substrate binding.
• Revealed that large-scale conformational changes are necessary to bring Thr379 into proximity with the heme iron for catalysis.
• Substrate analogs indicate that an indole-like side chain and L-stereoisomery are required for high-affinity binding.

Conclusions:

• Structural flexibility and specific amino acid residues (Thr379, Arg231) are critical for hIDO1 substrate binding and catalysis.
• Significant conformational rearrangements are involved in the activation of hIDO1.
• These findings provide a structural basis for designing potent and selective hIDO1-targeting cancer drugs.